Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,147
Closed -$1.09M 3505
2025
Q3
$1.09M Buy
16,147
+1,642
+11% +$109K 0.06% 526
2025
Q2
$945K Buy
14,505
+1,490
+11% +$89.3K 0.04% 699
2025
Q1
$804K Buy
+13,015
New +$862K 0.04% 684
2024
Q4
Sell
-7,819
Closed -$637K 2546
2024
Q3
$637K Buy
+7,819
New +$625K 0.05% 651
2024
Q2
Sell
-12,377
Closed -$965K 2119
2024
Q1
$965K Buy
12,377
+9,041
+271% +$673K 0.13% 173
2023
Q4
$238K Buy
3,336
+63
+2% +$4.39K 0.05% 818
2023
Q3
$227K Buy
+3,273
New +$247K 0.04% 937
2022
Q3
Sell
-4,735
Closed -$328K 1218
2022
Q2
$328K Sell
4,735
-493
-9% -$36.6K 0.13% 239
2022
Q1
$402K Buy
+5,228
New +$376K 0.18% 190
2021
Q2
Sell
-3,718
Closed -$277K 928
2021
Q1
$277K Buy
+3,718
New +$282K 0.13% 310

Other funds holding HOLX

XTX Topco's HOLX Position: Q4 2025 in Review

XTX Topco sold out of Hologic (HOLX) in Q4 2025, closing a stake of 16,147 shares — an estimated $1.09M sold.

XTX Topco first reported a position in HOLX in Q1 2021 and held it in 10 quarters. The position peaked at $1.09M in Q3 2025. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • XTX Topco reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 16,147 Hologic shares in Q4 2025, an estimated $1.09M.
  • XTX Topco first reported a position in Hologic in Q1 2021 and held it in 10 quarters.
  • XTX Topco's Hologic position peaked at $1.09M in Q3 2025.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.